Can a diabetes drug help dialysis patients? small study aims to find out
NCT ID NCT05687058
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early study is testing whether the diabetes and heart failure drug empagliflozin (Jardiance) is safe for people on dialysis for kidney failure. The drug is already approved for other uses but has not been studied in dialysis patients. Researchers will give 24 participants either a thrice-weekly or daily dose for three months, monitoring safety and how well they tolerate it. The goal is to gather information needed for a larger future trial.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Empagliflozin (Jardiance)
What this could lead to
If this study shows the drug is safe, it could pave the way for a larger trial testing whether empagliflozin protects the heart and remaining kidney function in dialysis patients.
What could go wrong
This is a very small, early feasibility study with only 24 participants. It is not designed to prove the drug works, and the drug has not been approved for dialysis patients. Safety risks are unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jackson Medicall Mall Dialysis Clinic
Jackson, Mississippi, 39213, United States
-
University of Mississippi Medical Center
Jackson, Mississippi, 39157, United States